Multiple Myeloma Hub

Multiple Myeloma Hub

Por: Scientific Education Support
The Multiple Myeloma Hub is an open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education in multiple myeloma. Our aim is to enhance knowledge in multiple myeloma, through the multichannel dissemination of global advances related to their classification, diagnosis, treatment, and management. Hosted on Acast. See acast.com/privacy for more information.
77 episodios disponibles

Latest episodes of the podcast Multiple Myeloma Hub

Mostrando página 3 de 4

Should 'cure' be the goal for multiple myeloma? 14/10/2021
Treating elderly and frail patients with MM: Cure versus disease control 07/10/2021
Is transplantation still relevant? If yes, in what context? 30/09/2021
The challenges of monitoring organ response in AL amyloidosis: What has been achieved so far? 24/09/2021
Is the treatment of high-risk SMM the way for achieving the cure? 23/09/2021
Does 'cure' have a different meaning in MM? 15/09/2021
How to treat first relapse in lenalidomide-refractory MM? 19/07/2021
With the unprecedented results seen with novel therapies, what is needed to overcome the poor prognosis of high-risk MM? 30/06/2021
When BCMA-directed therapy is not an option, how should we treat late relapse? 24/05/2021
What do you need to remember when facing CAR T-cell toxicities? 12/04/2021
What are the key additions to the new NCCN guidelines for multiple myeloma? 07/04/2021
If maintenance after induction reduces therapy options at relapse, is it still worth it? 01/04/2021
New findings on the role of the immune microenvironment presented at ASH 2020 16/02/2021
ASH 2020 discussion: Looking for the best partner for lenalidomide maintenance after auto-SCT 09/02/2021
Should we still use high-dose melphalan in the era of novel agents? 09/02/2021
What are the unmet needs in AL amyloidosis in Europe? 01/02/2021
ASH 2020 discussion: The role of upfront transplant consolidation in the era of novel agents 27/01/2021
Can single cell sequencing help to better define and monitor MM? 17/12/2020
My experience with novel immunotherapies 11/11/2020
How can we use the microbiome to improve cancer immunotherapy and alleviate side effect such as graft-versus-host-disease 08/07/2020
« Primera ‹ Anterior 1 2 3 4 Siguiente › Última »
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA